Outlook Therapeutics OTLK
NASDAQ OTLK
$0.62 0.00 (-0.19%)
As of: Sep 30, 2026 · 10:20 AM EDT

Outlook Therapeutics (OTLK) Total Current Liabilities (2015 - 2026)

Updated

Outlook Therapeutics' Total Current Liabilities came in at $28.68 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 8.9% from $31.49 million a year earlier and down 26.2% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Total Current Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Total Current Liabilities was $45.81 million, up 7.7% from FY2024.

  • Total Current Liabilities carries a five-year compound annual growth rate of 23.6% (FY2020 to FY2025).
  • Going back by fiscal year, Total Current Liabilities was $42.55 million in FY2024 (-8.9%), $46.73 million in FY2023 (+136.9%), $19.73 million in FY2022 (+192.2%) and $6.75 million in FY2021 (-57.5%).
  • The fiscal Q3 2026 figure represents the lowest quarterly Total Current Liabilities since fiscal Q2 2025.
  • Year-over-year, Total Current Liabilities increased in four of the last eight quarters, with an average decline of 3.4%.
  • The fastest year-over-year change in Total Current Liabilities over five years came in fiscal Q1 2024 (growth of 204.8%), and the weakest in fiscal Q4 2021 (a decline of 57.5%).
  • Business Quant data shows OTLK's Total Current Liabilities at $38.88 million (Q2 2026), $49.06 million (Q1 2026) and $45.81 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Outlook Therapeutics 84.78 Mn 49.03 Mn -8,265.00 28.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.68 Mn
Mar 31, 2026 38.88 Mn
Dec 31, 2025 49.06 Mn
Sep 30, 2025 45.81 Mn
Jun 30, 2025 31.49 Mn
Mar 31, 2025 24.82 Mn
Dec 31, 2024 48.24 Mn
Sep 30, 2024 42.55 Mn
Jun 30, 2024 42.55 Mn
Mar 31, 2024 54.08 Mn
Dec 31, 2023 45.97 Mn
Sep 30, 2023 46.73 Mn
Jun 30, 2023 49.93 Mn
Mar 31, 2023 43.53 Mn
Dec 31, 2022 15.08 Mn
Sep 30, 2022 19.73 Mn
Jun 30, 2022 18.43 Mn
Mar 31, 2022 31.41 Mn
Dec 31, 2021 19.95 Mn
Sep 30, 2021 6.75 Mn
API Access

Outlook Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=OTLK&period=max&api_key=YOUR_API_KEY